Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exosomal microRNA signaling refers to the process wherein microRNAs are selectively packaged into exosomes—small, membrane-bound extracellular vesicles—that are secreted from donor cells and taken up by recipient cells. These exosomal miRNAs act as potent regulators of gene expression, modulating cellular processes such as proliferation, differentiation, apoptosis, and immune activation by targeting mRNA molecules post-transcriptionally in recipient cells. This mechanism facilitates long-range intercellular communication, influencing tissue homeostasis, inflammation, regeneration, and pathology, notably in cancer progression and cardiovascular disease. Therapeutically, exosomal miRNAs are attractive both as disease biomarkers and as vehicles for drug delivery, but their complex biological roles and challenges in targeting specificity remain active areas of investigation.
Inhibition of exosome secretion (e.g., GW4869 inhibits sphingomyelinase to block miRNA packaging into exosomes); Modulation of exosomal miRNA levels (e.g., miRNA mimics or antagomirs); Engineered exosome delivery of miRNAs or drugs (targeting cancer cells, modulating immune response).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosomal microRNA signaling pathway (null).